Cargando…
Current and Emerging Pharmacotherapeutic Options for Smoking Cessation
Tobacco smoking remains the single most preventable cause of morbidity and mortality in developed countries and poses a significant threat across developing countries where tobacco use prevalence is increasing. Nicotine dependence is a chronic disease often requiring multiple attempts to quit; repea...
Autores principales: | Carson, Kristin V., Brinn, Malcolm P., Robertson, Thomas A., To-A-Nan, Rachada, Esterman, Adrian J., Peters, Matthew, Smith, Brian J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668891/ https://www.ncbi.nlm.nih.gov/pubmed/23772176 http://dx.doi.org/10.4137/SART.S8108 |
Ejemplares similares
-
Two-year efficacy of varenicline tartrate and counselling for inpatient smoking cessation (STOP study): A randomized controlled clinical trial
por: Carson-Chahhoud, Kristin V., et al.
Publicado: (2020) -
Correction: Two-year efficacy of varenicline tartrate and counselling for inpatient smoking cessation (STOP study): A randomized controlled clinical trial
por: Carson-Chahhoud, Kristin V., et al.
Publicado: (2021) -
Pharmacotherapeutic Options for Visceral Leishmaniasis—Current Scenario
por: Pandey, Krishna, et al.
Publicado: (2009) -
An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis
por: Ferretti, Francesca, et al.
Publicado: (2022) -
Multidisciplinary Pharmacotherapeutic Options for Nonalcoholic Fatty Liver Disease
por: Nakajima, Kei
Publicado: (2012)